Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Sciele Pharma Inc. acquires, develops, and markets prescription medicines within cardiovascular, obstetrical and gynaecological, paediatric and gastroenterological disorders More
Norgenix Pharmaceuticals is dedicated to the development, acquisition and partnering opportunities to commercialize and distribute OTC, BTC, and prescription medications for improved healthcare. More
Alliance pharmaceuticals is a dynamic UK pharmaceutical company with a successful acquisition and partnership track record More
Menarini is an Italian pharmaceutical company that focuses mainly on cardiovascular, oncology, pain, inflammation and asthma. More
King's College London Business Ltd is responsible for commercialisation of technologies emanating from King's. Opportunities include: Collaborative & Contract research, Consultancy, Clinical trials. More
Alcon is the worldwide leader in the discovery, development and manufacture of innovative ophthalmic products and technologies. More
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
Penwest is a specialty pharmaceutical company dedicated to bringing to the marketplace innovative products that help improve the lives of patients. More
LIBBS is now searching for new in-licensing or co-marketing opportunities for the territory of Brazil in key areas like Cardiology, CNS, HRT, Contraception, GI, Dermatology, Respiratory and Oncology. More
Cipher Pharmaceutical Ltd. is a research-pharmaceutical development company. More
Your selection
- Therapeutic target
- Metabolism del
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us